Accretion Nutraveda Limited (BOM:544694)

India · Delayed Price · Currency is INR

282.00

+3.00 (1.08%)

At close: Sep 9, 2026

Market Cap	1.95B
Revenue (ttm)	336.15M +5,645.6%
Net Income	50.68M
EPS	9.35
Shares Out	7.24M
PE Ratio	28.88
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Open	280.80
Previous Close	279.00
Day's Range	280.80 - 282.00
52-Week Range	129.00 - 313.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2026

About Accretion Nutraveda

Accretion Nutraveda Limited manufactures and supplies ayurvedic, nutraceutical, and wellness formulations in India and internationally. The company offers nutraceuticals products, including formulation for brain, memory and neuron care, UTI care, cardiac care, liver care, protein supplement, pediatric care, git care, effervescent, joint and bone care, immunity booster, gynec care, hair, skin, nail care, and infertility and PCOS care. It also provides ayurvedic products for bone and joint, respiratory, gynec, aphrodisiac, skin, digestive, hair, ... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 2021

Country India

Stock Exchange Bombay Stock Exchange

Ticker Symbol 544694

Full Company Profile

Financial Performance

In fiscal year 2026, Accretion Nutraveda's revenue was 336.15 million, an increase of 110.07% compared to the previous year's 160.02 million. Earnings were 50.68 million, an increase of 102.66%.

Financial Statements